S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.70 (-0.31%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)

Onconova Therapeutics (ONTX) News Today

$0.70
+0.02 (+2.87%)
(As of 03:15 PM ET)
SourceHeadline
MarketBeat logoStockNews.com Begins Coverage on Onconova Therapeutics (NASDAQ:ONTX)
americanbankingnews.com - February 20 at 2:28 AM
MarketBeat logoFutureWorld (OTCMKTS:FWDG) vs. Onconova Therapeutics (NASDAQ:ONTX) Head-To-Head Analysis
americanbankingnews.com - February 19 at 1:56 AM
MarketBeat logoOnconova Therapeutics (NASDAQ:ONTX) Receives New Coverage from Analysts at StockNews.com
americanbankingnews.com - February 13 at 4:32 AM
investing.com logoOnconova Therapeutics Inc (ONTX)
investing.com - February 13 at 12:22 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. (ONTX)
finance.yahoo.com - January 23 at 10:41 PM
benzinga.com logoOnconova Therapeutics Stock (NASDAQ:ONTX) Dividends: History, Yield and Dates
benzinga.com - December 21 at 11:07 PM
msn.com logoOnconova stock falls 10% on preclinical data for lymphoma drug
msn.com - December 12 at 4:02 PM
finance.yahoo.com logoOnconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
finance.yahoo.com - December 12 at 9:55 AM
finance.yahoo.com logoOnconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
finance.yahoo.com - December 8 at 6:47 PM
finance.yahoo.com logoOnconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
finance.yahoo.com - November 28 at 10:06 AM
finance.yahoo.com logoOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 16 at 12:48 PM
finanznachrichten.de logoOnconova Therapeutics, Inc.: Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
finanznachrichten.de - November 16 at 1:30 AM
finance.yahoo.com logoOnconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
finance.yahoo.com - November 14 at 6:28 PM
finance.yahoo.com logoOnconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
finance.yahoo.com - November 7 at 5:22 PM
benzinga.com logoOnconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCL
benzinga.com - November 2 at 7:56 PM
finance.yahoo.com logoOnconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCL
finance.yahoo.com - November 2 at 2:55 PM
markets.businessinsider.com logoPromising Developments in Onconova Therapeutics’ Drug Narazaciclib Bolster Buy Rating: An Analysis
markets.businessinsider.com - October 19 at 3:29 PM
finance.yahoo.com logoPromising Preclinical Narazaciclib Data Presented at MCL Meeting
finance.yahoo.com - October 19 at 10:29 AM
marketwatch.com logoOnconova Therapeutics Shares Rise 12% On Skin Cancer Treatment Data
marketwatch.com - October 12 at 5:04 PM
finance.yahoo.com logoEncouraging Rigosertib Data Presented at EADV as Late Breaker
finance.yahoo.com - October 12 at 12:04 PM
finance.yahoo.com logoOnconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
finance.yahoo.com - September 28 at 10:16 AM
finance.yahoo.com logoOnconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 6 at 8:54 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Onconova Therapeutics (ONTX)
markets.businessinsider.com - August 11 at 5:58 PM
finance.yahoo.com logoQ2 2023 Onconova Therapeutics Inc Earnings Call
finance.yahoo.com - August 11 at 5:58 PM
finance.yahoo.com logoOnconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
finance.yahoo.com - August 10 at 7:20 PM
finance.yahoo.com logoOnconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023
finance.yahoo.com - August 3 at 6:07 PM
finance.yahoo.com logoHere's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation
finance.yahoo.com - July 17 at 9:19 AM
finance.yahoo.com logoOnconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma
finance.yahoo.com - June 14 at 10:07 AM
msn.com logoHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Prior Recommendation
msn.com - June 7 at 3:30 AM
markets.businessinsider.com logoOnconova Therapeutics (ONTX) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - June 6 at 7:26 AM
finance.yahoo.com logoOnconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - June 5 at 9:20 AM
finance.yahoo.com logoOnconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade
finance.yahoo.com - May 25 at 8:28 AM
marketwatch.com logo8-K: Onconova Therapeutics, Inc.
marketwatch.com - May 17 at 3:52 PM
msn.com logoHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Buy Recommendation
msn.com - May 16 at 10:44 PM
markets.businessinsider.com logoOnconova Therapeutics (ONTX) Gets a Buy from Noble Financial
markets.businessinsider.com - May 16 at 12:42 PM
finanznachrichten.de logoOnconova Therapeutics, Inc.: Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
finanznachrichten.de - May 16 at 7:42 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Cara Therapeutics (CARA) and Minerva Neurosciences (NERV)
markets.businessinsider.com - May 16 at 7:42 AM
finance.yahoo.com logoQ1 2023 Onconova Therapeutics Inc Earnings Call
finance.yahoo.com - May 16 at 7:42 AM
msn.com logoOnconova Therapeutics: Q1 Earnings Insights
msn.com - May 15 at 9:41 PM
finance.yahoo.com logoOnconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 15 at 9:41 PM
investing.com logoOnconova Therapeutics (ONTX) Earnings Dates & Reports
investing.com - May 15 at 4:41 PM
finance.yahoo.com logoOnconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - May 15 at 4:41 PM
finance.yahoo.com logoOnconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer
finance.yahoo.com - May 12 at 8:12 AM
finance.yahoo.com logoOnconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer
finance.yahoo.com - May 11 at 8:43 AM
finance.yahoo.com logoOnconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium
finance.yahoo.com - May 8 at 8:16 AM
finance.yahoo.com logoOnconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023
finance.yahoo.com - May 4 at 8:18 PM
msn.com logoHC Wainwright & Co. Upgrades Onconova Therapeutics (ONTX)
msn.com - April 21 at 8:51 PM
finance.yahoo.com logoOnconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting
finance.yahoo.com - April 19 at 9:47 AM
finance.yahoo.com logoOnconova Therapeutics Announces the Unexpected Passing of Chief Medical Officer Dr. Mark Gelder
finance.yahoo.com - April 6 at 8:17 PM
markets.businessinsider.com logoOnconova Therapeutics (ONTX) Gets a Hold from H.C. Wainwright
markets.businessinsider.com - March 23 at 1:22 PM
Get Onconova Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter.



ONTX Media Mentions By Week

ONTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONTX
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

ONTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONTX Articles
This Week

2

1

ONTX Articles
Average Week

Get Onconova Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ONTX) was last updated on 2/23/2024 by MarketBeat.com Staff